NHS develops world-first bedside genetic test to prevent babies going deaf
A world-first genetic test, developed in Manchester, that could save the hearing of hundreds of babies each year has been successfully piloted in the NHS.
Read moreA world-first genetic test, developed in Manchester, that could save the hearing of hundreds of babies each year has been successfully piloted in the NHS.
Read moreProfessor Daniel Brison, Consultant Embryologist within Research and Innovation at MFT shares his personal motivation for his research journey in this area.
Read moreThree commonly prescribed statins are best placed to lower all the ‘bad’ types of cholesterol and prevent cardiovascular disease in people with diabetes, according to a new meta-analysis
Read moreA patient at Manchester University NHS Foundation Trust, is the first person in Europe to trial a new treatment for long-term (chronic) wounds.
Read moreGreater Manchester residents are being encouraged to take part in a major genetics study designed to improve health outcomes for South Asian people.
Read moreThree budding MFT entrepreneurs have been awarded places on the prestigious NHS Clinical Entrepreneur Programme.
Read moreTwo leading Manchester University NHS Foundation Trust (MFT) researchers have been appointed Senior Investigators by the National Institute for Health Research (NIHR).
Read moreThe results of the world’s first Phase 3 trials, of a new drug Gefapixant, show that it can ease the often distressing symptoms of chronic cough, with minimal side effects.
Read more